Analytes
|
Working range (pg/ml)
|
ASD Cases (n =84)
|
GP (n =159)
|
DD (n = 49)
|
---|
| |
% below MDL
|
% below MDL
|
% below MDL
|
---|
MCP-1
|
13.03 – 9,160
|
19.0
|
18.0
|
26.3
|
MIP-1α
|
6.1 – 28,800
|
0.0
|
1.2
|
4.1
|
RANTES
|
22.36 – 19,100
|
0.0
|
0.6
|
2.0
|
Eotaxin
|
1.37 – 9,200
|
19.0
|
9.0
|
14.3
|
IFN-γ
|
0.58 – 11,370
|
77.4
|
73.0
|
86.0
|
IL-1β
|
2.5 – 5,470
|
77.4
|
76.8
|
79.6
|
IL-2
|
1.45 – 9,530
|
67.9
|
69.2
|
83.7
|
IL-4
|
2.21 – 14,470
|
77.4
|
74.2
|
86.0
|
IL-6
|
1.88 – 12,360
|
77.4
|
74.8
|
79.6
|
IL-10
|
3.4 – 22,350
|
53.6
|
54.1
|
51.0
|
IL-5
|
1.75 – 11,490
|
100
|
100
|
100
|
IL-8
|
6.23 – 13,630
|
97.6
|
98.7
|
98.0
|
IL-12p40
|
2.74 – 6,000
|
100
|
99.4
|
100
|
TNF-α
|
3.96 – 8,660
|
100
|
99.4
|
100
|
IP-10
|
2.01 – 1,420
|
100
|
100
|
100
|
MIP-1β
|
5.3 – 10,370
|
96.4
|
94.3
|
98.0
|
GM-CSF
|
0.88 – 5,760
|
98.8
|
99.4
|
97.9
|
- ASD: Autism Spectrum Disorder; DD: developmental delay; GP: general population; MDL: minimal detection level.